Status:
RECRUITING
SpinChip Hs-cTnI Clinical Diagnostic Performance
Lead Sponsor:
SpinChip Diagnostics ASA
Collaborating Sponsors:
Aurevia
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
18+ years
Brief Summary
During a heart attack, the protein troponin I is released from the heart muscle into the bloodstream. Measurements of cardiac troponin in blood are used as an aid in the diagnosis of heart attack. The...
Detailed Description
Cardiac troponins are widely used as a biomarker to aid in the diagnosis of acute myocardial infarction (AMI). These structural proteins are essential in regulating contraction in cardiac muscle cells...
Eligibility Criteria
Inclusion
- Able and willing to provide signed written informed consent
- Subjects ≥ 18 years old
- Subjects presenting at the ED with acute chest discomfort including "pain", "pressure", "tightness", "burning", or "stabbing" and/or other symptoms suggestive of AMI such as upper abdominal pain, left shoulder/arm pain, pain in the jaw, or pain between the scapulae.
Exclusion
- Subjects experiencing shock
- Self-reported pregnancy
- Previously included in the study (e.g., in case of a second presentation)
- Patient incapable of judgement, for example due to severe pain
Key Trial Info
Start Date :
July 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT06499519
Start Date
July 15 2024
End Date
October 31 2025
Last Update
August 11 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus Universitetshospital
Aarhus, Denmark, DK-8200
2
Universitätsmedizin Göttingen (University Medical Center Göttingen)
Göttingen, Germany, 37099
3
Akershus University hospital, Akershus Clinical Research Center (ACR)
Lørenskog, Akerhus, Norway, 1474
4
Haukland University Hospital, Department of Heart Disease
Bergen, Vestland, Norway, 5021